Current Evidence and Future Directions for Colchicine in the Prevention of Atherosclerotic Cardiovascular Disease
Aimée Marjolijn Healey van Zelm, Aernoud T.L. Fiolet, Robert J. Hinchliffe, Shirley Jansen et autres
Chronic inflammation plays a key role in the development and progression of atherosclerotic cardiovascular disease (ASCVD) and its complications. Despite the use of blood pressure-, lipid-, and glucose-lowering therapies as well as antithrombotic agents, the lifetime residual cardiovascular (CV) risk in patients …
nl, gb, au, ca (code pays fourni par la source)